(NASDAQ: ATRC) Atricure's forecast annual revenue growth rate of 12.38% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 9.89%, and it is also forecast to beat the US market's average forecast revenue growth rate of 11.55%.
Atricure's revenue in 2025 is $465,307,000.On average, 4 Wall Street analysts forecast ATRC's revenue for 2025 to be $25,544,481,050, with the lowest ATRC revenue forecast at $25,514,664,492, and the highest ATRC revenue forecast at $25,574,297,609. On average, 4 Wall Street analysts forecast ATRC's revenue for 2026 to be $28,637,680,151, with the lowest ATRC revenue forecast at $28,494,365,152, and the highest ATRC revenue forecast at $28,808,661,006.
In 2027, ATRC is forecast to generate $32,113,899,828 in revenue, with the lowest revenue forecast at $32,113,899,828 and the highest revenue forecast at $32,113,899,828.